Recent News for IFRX - InflaRx N.V.

Date Title
May 21 InflaRx EPS beats by $0.20
May 21 InflaRx Reports Q1 2020 Financial & Operating Results
Apr 30 61 Stocks Moving In Thursday's Mid-Day Session
Apr 30 InflaRx up 11% premarket on bullish call at Raymond James
Apr 29 InflaRx EPS beats by €0.08
Apr 29 InflaRx Reports Full Year 2019 Financial & Operating Results
Apr 28 96 Biggest Movers From Yesterday
Apr 27 72 Stocks Moving In Monday's Mid-Day Session
Apr 14 We're Hopeful That InflaRx (NASDAQ:IFRX) Will Use Its Cash Wisely
Apr 1 Covid Report: Testing News Sends One Biotech Flying As Another Dives
Apr 1 Mid-Day Market Update: ProPetro Slides After Q4 Results; InflaRx Shares Jump
Apr 1 The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests
Mar 31 InflaRx doses first COVID-19 with IFX-1; shares up 24% after hours
Mar 31 InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology
Mar 31 17 Healthcare Stocks Moving In Tuesday's Pre-Market Session
Mar 7 Stocks To Watch: Fading The Fear
Mar 6 4 Smaller, Cash-Rich Biotech Stocks That Could Be Havens
Mar 3 InflaRx N.V. (IFRX) Presents At SVB Leerink Global Healthcare Conference - Slideshow
Mar 3 108 Biggest Movers From Yesterday
Mar 2 TLRY, GNW, PGEN and PI among after hours movers
Mar 2 NVAX, AIM, KPTI and CEI among midday movers
Feb 26 BYND, ALC among premarket gainers
Feb 26 InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum
Feb 19 InflaRx to Present at Upcoming SVB Leerink Global Healthcare Conference
Jan 17 InflaRx (IFRX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Back to the Main IFRX Page...